Literature DB >> 21919534

Characterization of sulfolipids of Mycobacterium tuberculosis H37Rv by multiple-stage linear ion-trap high-resolution mass spectrometry with electrospray ionization reveals that the family of sulfolipid II predominates.

Elizabeth R Rhoades1, Cassandra Streeter, John Turk, Fong-Fu Hsu.   

Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, is unique among bacterial pathogens in that it contains a wide array of complex lipids and lipoglycans on its cell wall. Among them, the sulfated glycolipid, termed the sulfolipid, is thought to mediate specific host-pathogen interactions during infection. Sulfolipids (SLs), including sulfolipid I (SL-I) and sulfolipid II (SL-II), are 2,3,6,6'-tetraacyltrehalose 2'-sulfates. SL-I was identified as a family of homologous 2-palmitoyl(stearoyl)-3-phthioceranoyl-6,6'-bis(hydroxyphthioceranoy1)trehalose 2'-sulfates and was believed to be the principal sulfolipid of M. tuberculosis strain H37Rv. We cultured and extracted sulfolipids using various conditions, including those originally described, and employed high-resolution multiple-stage linear ion-trap mass spectrometry with electrospray ionization to characterize the structure of the principal SL. We revealed that SL-II, a family of homologous 2-stearoyl(palmitoyl)-3,6,6'-tris(hydroxyphthioceranoy1)trehalose 2'-sulfates, rather than SL-I is the principal sulfolipid class. We identified a great number of isomers resulting from permutation of the various hydroxyphthioceranoyl substituents at positions 6 and 6' of the trehalose backbone for each of the SL-II species in the entire family. We redefined the structure of this important lipid family that was misassigned using the traditional methods 40 years ago.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21919534      PMCID: PMC3214629          DOI: 10.1021/bi2012178

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  SULFOLIPID FROM VIRULENT TUBERCLE BACILLI.

Authors:  G Middlebrook; C M Coleman; W B Schaefer
Journal:  Proc Natl Acad Sci U S A       Date:  1959-12       Impact factor: 11.205

2.  Mycobacterial sulfolipid shows a virulence by inhibiting cord factor induced granuloma formation and TNF-alpha release.

Authors:  Yuko Okamoto; Yukiko Fujita; Takashi Naka; Manabu Hirai; Ikuko Tomiyasu; Ikuya Yano
Journal:  Microb Pathog       Date:  2006-04-19       Impact factor: 3.738

3.  Deciphering sulfoglycolipids of Mycobacterium tuberculosis.

Authors:  Emilie Layre; Diane Cala-De Paepe; Gérald Larrouy-Maumus; Julien Vaubourgeix; Sathish Mundayoor; Buko Lindner; Germain Puzo; Martine Gilleron
Journal:  J Lipid Res       Date:  2011-04-11       Impact factor: 5.922

4.  Sulfolipid accumulation in Mycobacterium tuberculosis disrupted in the mce2 operon.

Authors:  Olivera Marjanovic; Anthony T Iavarone; Lee W Riley
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

5.  Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis.

Authors:  Joseph D Mougous; Christopher J Petzold; Ryan H Senaratne; Dong H Lee; David L Akey; Fiona L Lin; Sarah E Munchel; Matthew R Pratt; Lee W Riley; Julie A Leary; James M Berger; Carolyn R Bertozzi
Journal:  Nat Struct Mol Biol       Date:  2004-07-18       Impact factor: 15.369

6.  Sulfatides of Mycobacterium tuberculosis: the structure of the principal sulfatide (SL-I).

Authors:  M B Goren; O Brokl; B C Das
Journal:  Biochemistry       Date:  1976-06-29       Impact factor: 3.162

7.  MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence.

Authors:  Scott E Converse; Joseph D Mougous; Michael D Leavell; Julie A Leary; Carolyn R Bertozzi; Jeffery S Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

8.  The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis.

Authors:  Pilar Domenech; Michael B Reed; Cynthia S Dowd; Claudia Manca; Gilla Kaplan; Clifton E Barry
Journal:  J Biol Chem       Date:  2004-03-04       Impact factor: 5.157

9.  Sulfolipid I of Mycobacterium tuberculosis, strain H37RV. Nature of the acyl substituents.

Authors:  M B Goren; O Brokl; B C Das; E Lederer
Journal:  Biochemistry       Date:  1971-01-05       Impact factor: 3.162

10.  Synergistic action of cord factor and mycobacterial sulfatides on mitochondria.

Authors:  M Kato; M B Goren
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

View more
  9 in total

1.  Characterization of Hydroxyphthioceranoic and Phthioceranoic Acids by Charge-Switch Derivatization and CID Tandem Mass Spectrometry.

Authors:  Fong-Fu Hsu
Journal:  J Am Soc Mass Spectrom       Date:  2016-01-04       Impact factor: 3.109

2.  Structural determination of glycopeptidolipids of Mycobacterium smegmatis by high-resolution multiple-stage linear ion-trap mass spectrometry with electrospray ionization.

Authors:  Fong-Fu Hsu; Sophia Pacheco; John Turk; Georgiana Purdy
Journal:  J Mass Spectrom       Date:  2012-10       Impact factor: 1.982

3.  Lipid and Lipoarabinomannan Isolation and Characterization.

Authors:  Marie-Antoinette Lanéelle; Lucie Spina; Jérôme Nigou; Anne Lemassu; Mamadou Daffé
Journal:  Methods Mol Biol       Date:  2021

4.  Mass Spectrometry-Based Shotgun Lipidomics Using Charge-Switch Derivatization for Analysis of Complex Long-Chain Fatty Acids.

Authors:  Cheryl Frankfater; Fong-Fu Hsu
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Underestimated Manipulative Roles of Mycobacterium tuberculosis Cell Envelope Glycolipids During Infection.

Authors:  Andreu Garcia-Vilanova; John Chan; Jordi B Torrelles
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

6.  Palyosulfonoceramides A and B: unique sulfonylated ceramides from the Brazilian zoanthids Palythoa caribaeorum and Protopalythoa variabilis.

Authors:  Jose Gustavo L Almeida; Ana Isabel V Maia; Diego V Wilke; Edilberto R Silveira; Raimundo Braz-Filho; James J La Clair; Leticia V Costa-Lotufo; Otília Deusdenia L Pessoa
Journal:  Mar Drugs       Date:  2012-12-14       Impact factor: 5.118

7.  The Effect of Combining Natural Terpenes and Antituberculous Agents against Reference and Clinical Mycobacterium tuberculosis Strains.

Authors:  Elwira Sieniawska; Rafal Sawicki; Marta Swatko-Ossor; Agnieszka Napiorkowska; Agata Przekora; Grazyna Ginalska; Ewa Augustynowicz-Kopec
Journal:  Molecules       Date:  2018-01-15       Impact factor: 4.411

8.  Mycobacterium tuberculosis requires glyoxylate shunt and reverse methylcitrate cycle for lactate and pyruvate metabolism.

Authors:  Agnese Serafini; Lendl Tan; Stuart Horswell; Steven Howell; Daniel J Greenwood; Deborah M Hunt; Minh-Duy Phan; Mark Schembri; Mercedes Monteleone; Christine R Montague; Warwick Britton; Acely Garza-Garcia; Ambrosius P Snijders; Brian VanderVen; Maximiliano G Gutierrez; Nicholas P West; Luiz Pedro S de Carvalho
Journal:  Mol Microbiol       Date:  2019-08-23       Impact factor: 3.501

Review 9.  Trehalose and bacterial virulence.

Authors:  Muthita Vanaporn; Richard W Titball
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.